Areas of expertise: Parkinson’s disease, Huntington’s disease, aging, reactive oxygen species,C. elegans, genetics
Dr. Van Raamsdonk received a B.Sc. (Honours) in Biochemistry from the University of British Columbia in 1993. After completing a M.Sc. in Medical Science at McMaster University in 1999, Dr. Van Raamsdonk returned to the University of British Columbia to complete a Ph.D. in Medical Genetics in 2005. Subsequently, Dr. Van Raamsdonk became a postdoctoral fellow in the department of Biology at McGill University until joining the Van Andel Research Institute as an Assistant Professor in 2012. Throughout his research career, Dr. Van Raamsdonk has trained in eight unique research environments: Dr. Santosh Misra (genetics of plant resistance), Dr. Patrick Dennis (halophilic archaebacteria), Dr. Patricia Chang (gene therapy for hemophilia B), Dr. Peter Lansdorp (telomere biology), Dr. Michael Hayden (Huntington disease), Dr. Nicole Deglon and Dr. Patrick Aebischer (lentiviral gene therapy vectors), Dr. Blair Leavitt (Huntington disease) and Dr. Siegfried Hekimi (genetics of aging). Dr. Van Raamsdonk was the first recruit in VARI’s Center for Neurodegenerative Science.